Platelet versus plasma CXCL14, coronary artery disease, and clinical outcomes.

Res Pract Thromb Haemost · 2023 · PMC10225916 · PMID 37255851

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marked trendno p-value reported

On the other hand, there was a marked trend among patients with low circulating CXCL14 levels to have worse outcomes (composite outcome and ACM) when compared with those with higher circulating CXCL14 levels ( Figure 5 and Table 3 ).

also in 158 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.